Canadian Cannabis EV / EBITDA

Was ist das EV / EBITDA von Canadian Cannabis?

EV / EBITDA von Canadian Cannabis Corp. ist N/A

Was ist die Definition von EV / EBITDA?



EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.

Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.

EV / EBITDA von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Canadian Cannabis

Was macht Canadian Cannabis?

Canadian Cannabis Corp. focuses on the manufacture and marketing of medical marijuana products in Canada and internationally. The company intends to offer 15 different strains of dried marijuana, as well as the constituents to produce edible and elixir products for medicinal use. The company was founded in 2014 and is based in Brampton, Canada.

Unternehmen mit ev / ebitda ähnlich Canadian Cannabis